128 related articles for article (PubMed ID: 3085684)
1. The fate of [14C]-mesna in the rat.
Shaw IC; Graham MI; Jones MS
Arzneimittelforschung; 1986 Mar; 36(3):487-9. PubMed ID: 3085684
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
Ormstad K; Ohno Y
Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
Ormstad K; Orrenius S; Låstbom T; Uehara N; Pohl J; Stekar J; Brock N
Cancer Res; 1983 Jan; 43(1):333-8. PubMed ID: 6401168
[TBL] [Abstract][Full Text] [Related]
4. Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
Shaw IC; Weeks MS
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):933-5. PubMed ID: 3117563
[TBL] [Abstract][Full Text] [Related]
5. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
Reuther H; Kohl M; Wildenauer DB
Arzneimittelforschung; 1986 Apr; 36(4):763-5. PubMed ID: 3087373
[TBL] [Abstract][Full Text] [Related]
6. Interaction between mesna and selected transition metals in vitro and in vivo.
Shaw IC; Weeks MS
Arzneimittelforschung; 1986 Jun; 36(6):997-1000. PubMed ID: 3091043
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of orally administered mesna.
Burkert H; Lücker PW; Wetzelsberger N; Breuel HP
Arzneimittelforschung; 1984; 34(11):1597-600. PubMed ID: 6441581
[TBL] [Abstract][Full Text] [Related]
8. Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.
James CA; Rogers HJ
J Chromatogr; 1986 Oct; 382():394-8. PubMed ID: 3097045
[No Abstract] [Full Text] [Related]
9. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Brock N; Pohl J
IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Brock N; Stekar J
Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
[TBL] [Abstract][Full Text] [Related]
11. Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
Ormstad K; Uehara N
FEBS Lett; 1982 Dec; 150(2):354-8. PubMed ID: 6819161
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
James CA; Mant TG; Rogers HJ
Br J Clin Pharmacol; 1987 May; 23(5):561-8. PubMed ID: 3109461
[TBL] [Abstract][Full Text] [Related]
13. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Habs MR; Schmähl D
Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
[TBL] [Abstract][Full Text] [Related]
14. Reduction of dimesna to mesna by the isolated perfused rat liver.
Goren MP; Hsu LC; Li JT
Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and autoradiography of [3H] or [14C]stepholidine.
Zhang ZD; Zhou CM; Jin GZ; Zhang X; Yang L
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):289-92. PubMed ID: 2104478
[TBL] [Abstract][Full Text] [Related]
16. Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
Verschraagen M; Boven E; Torun E; Hausheer FH; Bast A; van der Vijgh WJ
Biochem Pharmacol; 2004 Aug; 68(3):493-502. PubMed ID: 15242815
[TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
18. Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.
Jones MS; Murrell RD; Shaw IC
Eur J Cancer Clin Oncol; 1985 May; 21(5):553-5. PubMed ID: 3924627
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
el-Yazigi A; Ernst P; al-Rawithi S; Legayada E; Raines DA
J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.
Verschraagen M; Zwiers TH; Torun E; Donker MG; Reinhoud NJ; Van der Vijgh WJ
J Pharm Sci; 2003 May; 92(5):1040-50. PubMed ID: 12712424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]